Parkman Healthcare Partners LLC
Parkman Healthcare Partners LLC reported 91 positions worth $1.11B as of September 30, 2026 (13F filed November 16, 2026). Largest holding: PTCT (4.1%). Biggest move: new buy SRRK ($26.1M).
| # | Symbol | Company | Value ↓ | % Port. | Shares | 1Y | YTD | Since reported |
|---|---|---|---|---|---|---|---|---|
| ▸ 1 | PTCT | $45.4M | 4.09% | 700,393 | — | — | -5.9% | |
| ▸ 2 | LLY | $44.1M | 3.97% | 38,119 | — | — | +23.7% | |
| ▸ 3 | MBX | $42.0M | 3.78% | 716,542 | — | — | -9.4% | |
| ▸ 4 | IQV | $39.0M | 3.52% | 145,221 | — | — | -1.5% | |
| ▸ 5 | DXCM | $37.7M | 3.40% | 437,034 | — | — | -5.4% | |
| ▸ 6 | INBX | $36.1M | 3.25% | 360,260 | — | — | -22.4% | |
| ▸ 7 | VRDN | $34.5M | 3.11% | 1,674,834 | — | — | +49.9% | |
| ▸ 8 | URGN | $30.5M | 2.75% | 750,202 | — | — | -30.8% | |
| ▸ 9 | SRRK | $26.1M | 2.35% | 540,000 | — | — | -7.8% | |
| ▸ 10 | CVS | $24.5M | 2.21% | 286,286 | — | — | +3.4% |
Read the 2026-Q2 quarterly report · 13F Filing Calendar
Frequently Asked Questions
What stocks does Parkman Healthcare Partners LLC hold as of Q3 2026?
Parkman Healthcare Partners LLC reported 91 positions worth $1.11B in its Q3 2026 13F filing. Largest positions: PTCT (4.1%), LLY (4.0%), MBX (3.8%), IQV (3.5%) and DXCM (3.4%).
What did Parkman Healthcare Partners LLC buy in Q3 2026?
New positions: SRRK, CRL, KOD, ABT and WST (27 in all). Added to: URGN, PTCT, ANRO, IQV and INBX (31 in all).
What did Parkman Healthcare Partners LLC sell in Q3 2026?
Reduced: EWTX, PODD, CVS, THC and DXCM (32 in all). Sold out entirely: SYK, ZBH, BCRX, QURE and AMRX (13 in all).
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.